Bora Pharmaceuticals

As a part of our Facility Spotlight series, we're highlighting our recently-acquired 87,000 sq. ft. Baltimore, MD, USA facility. 🏭 This facility in Baltimore specializes in aseptic fill/finish services for clinical and commercial sterile injectables, including formulation, filling, inspection, packaging, and analytical services. Experienced in handling mAbs, recombinant proteins and other biological products, this facility offers flexible and scalable solutions for your complex cGMP manufacturing programs. Facility Highlights: ✔️ A state-of-the-art groninger FlexPro 50 Isolator Filling Line capable of filling vials, syringes, and cartridges ✔️ Lyophilization capabilities ✔️ Vials ✔️ Prefilled Syringes Want to learn more about our fill/finish capabilities? 👉 https://bit.ly/3B2x4TN #sterileinjectables #cdmo #vials

Scaling biologics for commercial production is a complex journey full of challenges. 🧬 As the demand for these innovative therapies continues to rise, biotech companies must navigate issues like maintaining product quality, ensuring process robustness, and managing costs effectively. Our latest blog reveals how open communication, real-time feedback, and proactive risk mitigation strategies are key to overcoming your scaling hurdles and achieving project success. Find out how our expertise in biologics development and manufacturing can help streamline your path to commercialization. 👇 https://bit.ly/4ggM92H #Biologics #CDMO #Scalability

From the Bora family to yours: wishing all of our U.S. clients, colleagues and suppliers a happy and joyful Thanksgiving! #Thanksgiving2024

According to a press release from BioSpace, the global topical drug delivery market size was valued at USD 131.87 billion in 2024 and is anticipated to reach around USD 238.38 billion by 2033, growing at a CAGR of 6.8 % from 2024 to 2033. At Bora, we combine our long history of successful tech transfer with our technical and analytical expertise and flexible manufacturing capacities to manufacture and package a broad range of prescription and over-the-counter semi-solid drug products including creams, gels, and ointments. Learn more about Bora's semi-solid expertise or speak with an expert here 👉https://bit.ly/3Z6Epe4 #cdmo #pharma

Navigating the rapid growth and increasing complexity of biologics presents a unique challenge: scaling manufacturing processes to meet the escalating demand. Download our latest eBook and learn strategies for enhancing early drug development to future-proof later stages 👇 https://bit.ly/40KBrNI

Did you know… At Bora, we support our customers across many dosage forms, including (but not limited to!): OSD, liquids, nasal sprays, and semi-solids! 💧🧪 Our North American and Asian sites are strategically designed for a seamless scale-up, ensuring a smooth transition from clinical to commercial manufacturing and packaging. The secret? Our unique manufacturing suite design and the similarity in technologies used across development phases guarantee flexibility for any dosage form. Find out more here or contact an expert here 👉 https://bit.ly/4eDts8w

Happy Veterans Day from all of us at Bora. Today, we remember and honor all who have served or are actively serving. Thank you, veterans!

Enjoying the final day of a productive #BioEurope! Make sure you connect with Steven C. Huang, MBA today on the show floor or here on LinkedIn to discuss how Bora and our comprehensive service offering can help accelerate your program! #BioPharma #Biologics #CDMO #PharmaManufacturing

As a part of our Facility Spotlight series, we're highlighting our recently-acquired 87,000 sq. ft. Baltimore, MD, USA facility. 🏭 This facility in Baltimore specializes in aseptic fill/finish services for clinical and commercial sterile injectables, including formulation, filling, inspection, packaging, and analytical services. Experienced in handling mAbs, recombinant proteins and other biological products, this facility offers flexible and scalable solutions for your complex cGMP manufacturing programs. Facility Highlights: ✔️ A state-of-the-art groninger FlexPro 50 Isolator Filling Line capable of filling vials, syringes, and cartridges  ✔️ Lyophilization capabilities  ✔️ Vials  ✔️ Prefilled Syringes  Want to learn more about our fill/finish capabilities? 👉 https://bit.ly/3Cd1vXg

In our latest eBook, Bora experts discuss key strategies for enhancing early biologics drug development to future-proof later stages and successfully bring your drug product to market. Insights Include: 🔎Identifying and implementing the most effective cell line development (CLD) strategy to overcome challenges and streamline production 📈 The importance of analytics ✅ Tactics enabling analytical success for CLD 📖 Client case study highlighting Bora’s expertise and approach to cell line development Download the eBook here 👉 https://lnkd.in/geaBWJkK